Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Total Debt (2024 - 2025)

Historic Total Debt for Nuvation Bio (NUVB) over the last 2 years, with Q3 2025 value amounting to $52.7 million.

  • Nuvation Bio's Total Debt rose 52552.81% to $52.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.7 million, marking a year-over-year increase of 52552.81%. This contributed to the annual value of $6.3 million for FY2024, which is N/A changed from last year.
  • Nuvation Bio's Total Debt amounted to $52.7 million in Q3 2025, which was up 52552.81% from $52.6 million recorded in Q2 2025.
  • Nuvation Bio's Total Debt's 5-year high stood at $52.7 million during Q3 2025, with a 5-year trough of $5.7 million in Q1 2025.